High "bad" cholesterol, or hypercholesterolemia, affects about 10% of adults in the United States and about 7% of youth, ...

Escalated doses of lomitapide (5–10 mg/day; orally) with or without ezetimibe have been tested in patients with moderate hypercholesterolemia for a period of 12 weeks. The results indicated a ...

Familial Hypercholesterolemia "The justly celebrated unraveling of the LDL receptor pathway revealed that mutations in a ...

No writing assistance was utilized in the production of this manuscript. Homozygous familial hypercholesterolemia is a rare but significant cause of early-onset coronary heart disease. Early ...

Heterozygous familial hypercholesterolemia was associated with increased type 2 diabetes risk, especially among those with obesity and statin use.

WASHINGTON, Oct. 31, 2024 /PRNewswire/ -- As part of its ongoing commitment to raise awareness about heart health and address ...

Considering taking supplements to treat familial hypercholesterolemia? Below is a list of common natural remedies used to treat or reduce the symptoms of familial hypercholesterolemia. Follow the ...

Spain: A recent phase 3 study, published in The Lancet Diabetes & Endocrinology, has demonstrated the effectiveness of ...

Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Verve Therapeutics (VERV – Research Report) and decreased the ...

CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and ...

Managing DME/DR Lifestyle changes: Strict control of diabetes, hypertension, and hypercholesterolemia, along with dietary ...

Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.